Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab Read more
NOVASEP And LYSOGENE Announce Their New Collaboration For Development And Production Of GM1 Gangliosidosis Gene Therapy Product Read more
Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801 Read more
Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb Read more
FDA Approves Dupixent (dupilumab) for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis Read more